Post-transplant Lymphoproliferative Disorder Successfully Treated with Pola-R-CHP and Achieved Long-term Remission

Post-transplant lymphoproliferative disorder (PTLD) is a life-threatening condition for organ transplantations. There are no established treatments for PTLD, and it is associated with a poor prognosis. Patients with PTLD treated with Pola-R-CHP have rarely been reported, and long-term remission results are unknown. This is the first report of previously untreated PTLD treated with a Pola-R-CHP regimen that achieved long-term remission. Pola-R-CHP may be a promising treatment option for patients with PTLD, especially monomorphic diffuse large B-cell lymphoma, and those with an increased International Prognostic Index score.